Literature DB >> 33608636

Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection.

Philipp A Reuken1, Andreas Stallmach2, Mathias W Pletz3, Christian Brandt3, Nico Andreas4, Sabine Hahnfeld5, Bettina Löffler6, Sabine Baumgart4,7, Thomas Kamradt4,7, Michael Bauer8.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33608636      PMCID： PMC7893131          DOI： 10.1038/s41375-021-01175-8

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

1.  Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.

Authors:  Xingguang Li; Junjie Zai; Qiang Zhao; Qing Nie; Yi Li; Brian T Foley; Antoine Chaillon
Journal:  J Med Virol       Date:  2020-03-11       Impact factor: 2.327

2.  Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.

Authors:  Jérôme Hadjadj; Nader Yatim; Darragh Duffy; Frédéric Rieux-Laucat; Solen Kernéis; Benjamin Terrier; Laura Barnabei; Aurélien Corneau; Jeremy Boussier; Nikaïa Smith; Hélène Péré; Bruno Charbit; Vincent Bondet; Camille Chenevier-Gobeaux; Paul Breillat; Nicolas Carlier; Rémy Gauzit; Caroline Morbieu; Frédéric Pène; Nathalie Marin; Nicolas Roche; Tali-Anne Szwebel; Sarah H Merkling; Jean-Marc Treluyer; David Veyer; Luc Mouthon; Catherine Blanc; Pierre-Louis Tharaux; Flore Rozenberg; Alain Fischer
Journal:  Science       Date:  2020-07-13       Impact factor: 47.728

3.  Moderate mutation rate in the SARS coronavirus genome and its implications.

Authors:  Zhongming Zhao; Haipeng Li; Xiaozhuang Wu; Yixi Zhong; Keqin Zhang; Ya-Ping Zhang; Eric Boerwinkle; Yun-Xin Fu
Journal:  BMC Evol Biol       Date:  2004-06-28       Impact factor: 3.260

4.  Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands.

Authors:  Jaap van Doesum; Anabelle Chinea; Maria Pagliaro; Maria Cristina Pasquini; Tom van Meerten; Martijn Bakker; Emanuele Ammatuna
Journal:  Leukemia       Date:  2020-07-08       Impact factor: 11.528

5.  Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia.

Authors:  Lindsey E Roeker; David A Knorr; Melissa S Pessin; Lakshmi V Ramanathan; Meghan C Thompson; Lori A Leslie; Andrew D Zelenetz; Anthony R Mato
Journal:  Leukemia       Date:  2020-08-27       Impact factor: 11.528
  5 in total
  12 in total

1.  [Guideline S1: Long COVID: Diagnostics and treatment strategies].

Authors:  Susanne Rabady; Johann Altenberger; Markus Brose; Doris-Maria Denk-Linnert; Elisabeth Fertl; Florian Götzinger; Maria de la Cruz Gomez Pellin; Benedikt Hofbaur; Kathryn Hoffmann; Renate Hoffmann-Dorninger; Rembert Koczulla; Oliver Lammel; Bernd Lamprecht; Judith Löffler-Ragg; Christian A Müller; Stefanie Poggenburg; Hans Rittmannsberger; Paul Sator; Volker Strenger; Karin Vonbank; Johannes Wancata; Thomas Weber; Jörg Weber; Günter Weiss; Maria Wendler; Ralf-Harun Zwick
Journal:  Wien Klin Wochenschr       Date:  2021-12-01       Impact factor: 1.704

Review 2.  Use of convalescent plasma in COVID-19 patients with immunosuppression.

Authors:  Jonathon W Senefeld; Stephen A Klassen; Shane K Ford; Katherine A Senese; Chad C Wiggins; Bruce C Bostrom; Michael A Thompson; Sarah E Baker; Wayne T Nicholson; Patrick W Johnson; Rickey E Carter; Jeffrey P Henderson; William R Hartman; Liise-Anne Pirofski; R Scott Wright; De Lisa Fairweather; Katelyn A Bruno; Nigel S Paneth; Arturo Casadevall; Michael J Joyner
Journal:  Transfusion       Date:  2021-06-01       Impact factor: 3.337

Review 3.  SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise.

Authors:  Ralf Duerr; Keaton M Crosse; Ana M Valero-Jimenez; Meike Dittmann
Journal:  Microorganisms       Date:  2021-06-27

4.  Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia.

Authors:  P Guisado-Vasco; M M Carralón-González; J Aguareles-Gorines; E M Martí-Ballesteros; M D Sánchez-Manzano; D Carnevali-Ruiz; M García-Coca; R Barrena-Puertas; R García de Viedma; J M Luque-Pinilla; G Sotres-Fernandez; J M Fernández-Sousa; X E Luepke-Estefan; J A López-Martín; J M Jimeno
Journal:  J Hematol Oncol       Date:  2022-01-10       Impact factor: 17.388

5.  Human Nasal Epithelial Cells Sustain Persistent SARS-CoV-2 Infection In Vitro, despite Eliciting a Prolonged Antiviral Response.

Authors:  Akshamal M Gamage; Kai Sen Tan; Wharton O Y Chan; Zhe Zhang Ryan Lew; Jing Liu; Chee Wah Tan; Deepa Rajagopalan; Quy Xiao Xuan Lin; Le Min Tan; Prasanna Nori Venkatesh; Yew Kwang Ong; Mark Thong; Raymond Tzer Pin Lin; Shyam Prabhakar; De Yun Wang; Lin-Fa Wang
Journal:  mBio       Date:  2022-01-18       Impact factor: 7.867

6.  RNA SARS-CoV-2 Persistence in the Lung of Severe COVID-19 Patients: A Case Series of Autopsies.

Authors:  Tamara Caniego-Casas; Laura Martínez-García; Marina Alonso-Riaño; David Pizarro; Irene Carretero-Barrio; Nilda Martínez-de-Castro; Ignacio Ruz-Caracuel; Raúl de Pablo; Ana Saiz; Rosa Nieto Royo; Ana Santiago; Marta Rosas; José L Rodríguez-Peralto; Belén Pérez-Mies; Juan C Galán; José Palacios
Journal:  Front Microbiol       Date:  2022-01-31       Impact factor: 5.640

7.  Prolonged SARS-CoV-2 infection associated with long-term corticosteroid use in a patient with impaired B-cell immunity.

Authors:  Momoko Morishita; Manabu Suzuki; Akihiro Matsunaga; Keishi Ishizhima; Tsukasa Yamamoto; Yudai Kuroda; Takayuki Kanno; Yoshie Tsujimoto; Akane Ishida; Masao Hashimoto; Satoru Ishii; Jin Takasaki; Go Naka; Motoyasu Iikura; Shinyu Izumi; Tadaki Suzuki; Ken Maeda; Yukihito Ishizaka; Masayuki Hojo; Haruhito Sugiyama
Journal:  J Infect Chemother       Date:  2022-02-10       Impact factor: 2.065

Review 8.  Challenges and Management of Long COVID in Individuals with Hematological Illnesses.

Authors:  Dana Yelin; Ili Margalit
Journal:  Acta Haematol       Date:  2022-02-08       Impact factor: 3.068

9.  Management of Persistent SARS-CoV-2 Infection in Patients with Follicular Lymphoma.

Authors:  Pilar Martínez-Barranco; María García-Roa; Roberto Trelles-Martínez; Karmele Arribalzaga; María Velasco; Carlos Guijarro; Javier Marcos; Carolina Campelo; Juan Manuel Acedo-Sanz; Lucía Villalón; Pilar Ricard; María José García-Bueno; Elia Pérez-Fernández; Gil Rodríguez-Caravaca; Francisco-Javier Peñalver
Journal:  Acta Haematol       Date:  2021-11-26       Impact factor: 3.068

Review 10.  Imaging of Hematological Patients in the Era of COVID-19.

Authors:  Yael Eshet; Abraham Avigdor; Meirav Kedmi; Noam Tau
Journal:  Acta Haematol       Date:  2022-01-31       Impact factor: 3.068
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.